Skip to Content
MilliporeSigma

Oral pyogenic granuloma in hemophilia: a report of 2 cases.

Journal of pediatric hematology/oncology (2014-03-26)
Holly Lindsay, Lakshmi V Srivaths
ABSTRACT

Pyogenic granulomas (PGs) are benign vascular lesions occurring in skin and mucous membranes, often secondary to trauma or chronic inflammation. Oral PGs have never been described previously in hemophilia. We describe 2 pediatric patients with hemophilia A, who developed PGs with inadequate factor therapy for bleeding. PG pathophysiology suggests an association with hemophilia given chronic vascular damage and low-grade inflammation at sites of bleeding in hemophilia patients. Knowledge about the occurrence of PGs in hemophilia patients is essential for prompt diagnosis and early institution of factor therapy, which in turn allows more rapid cessation of bleeding and lesion involution.

MATERIALS
Product Number
Brand
Product Description

Human coagulation factor VIII concentrate, European Pharmacopoeia (EP) Reference Standard
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
1 g
Estimated to ship on March 24, 2025
$53.20
5 g
Estimated to ship on March 24, 2025
$208.00
10 g
Estimated to ship on March 24, 2025
$431.00